http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DO-P2011000307-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a9e6421e9257148abad101e1ce6c162
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D489-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-08
filingDate 2011-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e64accdfdcfa2c626a65e9cb49f89107
publicationDate 2011-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DO-P2011000307-A
titleOfInvention N-ALQUIL-NALTREXONA HALOGENURE PREPARATION PROCEDURE
abstract The invention relates to a new process for the preparation of N-methyl-naltrexone bromide, which comprises at least the steps consisting of: (i) reacting the N-methyl-naltrexone methylsulfate in aqueous solution with a chosen alkaline agent from the group consisting of sodium carbonate, potassium carbonate, calcium carbonate, magnesium carbonate, cesium carbonate, strontium carbonate and their mixtures, for a pH of the aqueous reaction medium between 7 and 10, and then ( ii) reacting the product thus obtained with the hydrobromic acid that is added, for a pH of the aqueous reaction medium between 0.5 and 5, and thus obtaining the bromide of N-methyl-naltrexone.
priorityDate 2006-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16088038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410023599
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4694097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426748271
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454570538
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448769888
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450513458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448098817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10796
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15407
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449625689
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10340
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453467280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448020525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5361917

Total number of triples: 35.